What Researchers Did
Researchers conducted a retrospective study across multiple institutions to compare death rates in patients with Fournier's Gangrene who received standard treatment (surgery and/or antibiotics) either alone or combined with hyperbaric oxygen therapy.
What They Found
Out of 161 patients with Fournier's Gangrene, 72 (44.7%) received hyperbaric oxygen therapy (HBOT). The study found that the death rate was 36.0% for patients who did not receive HBOT, compared to 19.4% for those who did. Both HBOT and surgical debridement were identified as independent factors linked to a lower risk of death.
Canadian Relevance
No direct Canadian connection identified.
Study Limitations
This was a retrospective observational study, meaning it looked back at existing patient data, which can introduce biases and does not prove that HBOT directly caused the reduced mortality.